Laxacin
- Product NDC
- 80425-0345
- 11-digit product format
- 804250345
- Labeler code
- 80425
- Product ID
- 80425-0345_2a9c2eb6-a6dc-f647-e063-6294a90a93fe
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate sodium and sennosides
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-06-19
- Substance
- DOCUSATE SODIUM; SENNOSIDES A AND B
- Active strength
- 50; 8.6 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| F05Q2T2JA0 | DOCUSATE SODIUM | 577-11-7 | DOCUSATE SODIUM |
| 1B5FPI42EN | SENNOSIDES A AND B | 62211-03-4 | SENNOSIDES A AND B |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 80425-0345-1 | 80425034501 | 100 TABLET in 1 BOTTLE (80425-0345-1) | 100 tablet | 2023-06-19 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Laxacin Tablets | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN OTC DRUG LABEL | 2 |